PM360

NOVEMBER 14, 2023

This collaboration builds on Sanofi’s recent announcement to lower the list price for Lantus and cap OOP costs at $35 for all patients with commercial insurance, which goes into effect January 1, 2024. retail pharmacies to access a 30-day supply of Lantus for only $35. “We References: 1.

Retail 52

Retail Pharmaceutical manufacturing Sales Insurance 52

Impetus Digital

NOVEMBER 23, 2023

With the end of the year quickly approaching, you will likely see multiple articles on the key trends of 2023 and predictions for 2024 start popping up. Many of these will discuss the expanding role and capabilities of AI and machine learning in the Pharma space. It really is all about personalization and preference.

Education 52

Education Healthcare Provider Physicians Pharma 52

European Pharmaceutical Review

OCTOBER 10, 2024

The introduction of rapid microbiological testing methods, such as biofluorescent particle counters for real time detection of microbial contamination, has had an important impact on cell and gene therapy manufacturing. Environmental Monitoring In-Depth Focus 2024 How is eXmoor navigating these advances in the sector?

Manufacturing 52

Manufacturing Safety Pharmaceutical manufacturing Consulting 52

PM360

MAY 21, 2024

Pharmaceutical manufacturers know how important adherence to a treatment plan is and to help patients afford medications, manufacturer assistance programs are designed to make treatments more affordable. When treatments are missed or reduced, health outcomes suffer.

Electronics 52

Electronics Prescription Pharmaceutical manufacturing Patients 52

pharmaphorum

DECEMBER 16, 2022

The negotiations over the treaty are being hosted through the World Health Organization (WHO), with plans to officially adopt a binding agreement sealed by the United Nations health agency’s member countries in May 2024. The discussions over the treaty are set to continue for some time.

Distribution 77

Distribution Pharmaceutical manufacturing Manufacturing Pharmaceutical 77

European Pharmaceutical Review

JULY 21, 2023

Recent guidance published by the European Medicines Agency outlines measures that will be taken to increase preparedness for the autumn/winter 2023-2024. Recommendations were also published earlier this year for all stakeholders in the pharma supply chain.

Pharmaceutical 98

Pharmaceutical Food and Drug Administration Transportation Manufacturing 98

pharmaphorum

NOVEMBER 25, 2022

The Parma site, as yet only nine months into construction, is due to become operational from 2024, with FDA, IFA, and EMA approvals due to be sought for 2025. In brief, the European plan for Chiesi is in-house drug development of biologicals and rare disease targeting.

Pharmaceutical 94

Pharmaceutical Manufacturing Medicine Competition 94

PM360

MAY 21, 2024

It’s a powerful technology that, if used correctly, can help us all reach new heights in pharmaceutical manufacturing and beyond. This article will explore how to set yourself up for success when using AI within the pharma manufacturing space. It is easy and understandable to get swept into the hype around AI.

Manufacturing 52

Manufacturing Pharma Education Pharmaceutical manufacturing 52

Pharmaceutical Technology

DECEMBER 19, 2022

This economic change impacts employment, income, industrial production, and more, and the pharmaceutical industry will not be exempt. by the end of 2023 and may continue to rise in 2024 to 5%. Pierre Socha, partner at Amadeus Capital Partners, London, UK, predicts that larger pharmaceutical companies may have similar interests.

Pharmaceutical 69

Pharmaceutical Manufacturing Medicine Government 69

Clarivate

AUGUST 20, 2024

Announced on August 15, 2024, this first batch of Maximum Fair Prices (MFPs) were mandated by the Inflation Reduction Act of 2022 , which allowed CMS to negotiate what it describes as the maximum fair price for therapies representing the greatest cost to Medicare.

Manufacturing 52

Manufacturing Government Prescription Pharmaceutical manufacturing 52